{"meta":{"query_hash":"6b4bed8a19df","filters":{"venue":"Biotechnology Law Report"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6b4bed8a19df","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biotechnology+Law+Report"},"results":[{"id":"W1967718889","doi":"10.1089/blr.2004.23.556","title":"Patenting of \"Higher Life Forms\" in Canada","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; European union; Political science; Library science; Law; Biology; Business; International trade","score_opus":0.02110794340125666,"score_gpt":0.21907132449178793,"score_spread":0.19796338109053127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967718889","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2512853,0.010195876,0.0033017,0.06278846,0.0015677771,0.00051030307,0.003582808,0.00039496433,0.6663728],"genre_scores_gemma":[0.55955106,0.0059055793,0.0027302888,0.016006267,0.00024108219,0.00011577845,0.0011848462,0.00007746585,0.41418776],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937895,0.00022340137,0.00020686408,0.00046100403,0.003433645,0.0018855841],"domain_scores_gemma":[0.98970795,0.002857128,0.00038557785,0.00042211966,0.005136165,0.0014911704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002771871,0.00030871632,0.00051574304,0.0032861019,0.010919819,0.0070708925,0.0019565756,0.0054014972,0.008407077],"category_scores_gemma":[0.009685197,0.0005524434,0.0007542177,0.0029704703,0.003187731,0.0016687402,0.0013757154,0.0039551933,0.00046231083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004187466,0.0002701094,0.015967345,0.00054381957,0.00007634791,0.0013927273,0.004700004,0.0022299772,0.00852173,0.63871557,0.19712994,0.13003379],"study_design_scores_gemma":[0.00015300322,0.00021777127,0.07703735,0.0002580739,0.00010294137,0.0002361886,0.0017474191,0.002309591,0.0062532653,0.010988914,0.900536,0.00015956101],"about_ca_topic_score_codex":0.9923361,"about_ca_topic_score_gemma":0.99546707,"teacher_disagreement_score":0.08139713,"about_ca_system_score_codex":0.08139713,"about_ca_system_score_gemma":0.19433342,"threshold_uncertainty_score":0.5905803},"labels":[],"label_agreement":null},{"id":"W2029144942","doi":"10.1089/blr.2013.9911","title":"The Pharmaceutical/Biopharmaceutical Landscape—Traversing Canada's Patent and Regulatory Regimes","year":2013,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biopharmaceutical; Traverse; Patent law; Download; Intellectual property; Political science; Law; Biotechnology; Biology; Geography; Computer science; Cartography","score_opus":0.07683336325037865,"score_gpt":0.22689901464428647,"score_spread":0.15006565139390782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029144942","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045979924,0.013984686,0.0022357316,0.5685013,0.0014043279,0.000121226825,0.00069384946,0.00015218278,0.36692673],"genre_scores_gemma":[0.5785026,0.014225686,0.0052932184,0.26020324,0.0010949775,0.00009208403,0.00028705253,0.00019174213,0.14010932],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.97751415,0.0015491436,0.0005166014,0.0014717992,0.013097572,0.005850796],"domain_scores_gemma":[0.9678113,0.008533381,0.001263433,0.0010192719,0.014408893,0.006963723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0113022765,0.0004617172,0.0007285192,0.0051776567,0.03476874,0.030437086,0.0032328793,0.016953135,0.008938301],"category_scores_gemma":[0.019333519,0.00084105687,0.0011530377,0.0051072002,0.02013876,0.007311871,0.0047181654,0.015033658,0.0006015558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00006418214,0.00009424748,0.0031494377,0.00012552993,0.000028236762,0.0003921494,0.0025672072,0.00060737086,0.0010890885,0.8122969,0.13346973,0.04611591],"study_design_scores_gemma":[0.00007621297,0.0000773916,0.020092404,0.0006717077,0.00007285628,0.00017896041,0.0050129057,0.0014012887,0.001157642,0.0836701,0.88736695,0.00022159927],"about_ca_topic_score_codex":0.9874742,"about_ca_topic_score_gemma":0.9947259,"teacher_disagreement_score":0.81191003,"about_ca_system_score_codex":0.18808994,"about_ca_system_score_gemma":0.39074787,"threshold_uncertainty_score":0.9417006},"labels":[],"label_agreement":null},{"id":"W2031108337","doi":"10.1089/blr.2012.9750","title":"Securities Fraud Class Action Lawsuits Against Life Science Companies on the Rise in the First Quarter 2012","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Legal Education and Practice Innovations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Class action; Quarter (Canadian coin); Action (physics); Class (philosophy); Business; Law; Securities fraud; Political science; History; State (computer science); Computer science; Supreme court","score_opus":0.06849701425227893,"score_gpt":0.36705103032902103,"score_spread":0.2985540160767421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031108337","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34507972,0.004838008,0.0017572735,0.38730672,0.0043936865,0.00035385933,0.0029540437,0.00056460133,0.2527521],"genre_scores_gemma":[0.61633843,0.002016732,0.0007603682,0.12814985,0.0025605296,0.00019959669,0.001288039,0.0000776949,0.24860866],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9919322,0.0007167074,0.00039829532,0.0005779734,0.003825519,0.0025493612],"domain_scores_gemma":[0.98112947,0.0075932583,0.0035422393,0.00074607396,0.0042904327,0.00269852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006031029,0.0004772566,0.0006704786,0.0028322265,0.006855504,0.00790277,0.0012818188,0.021815544,0.0088672135],"category_scores_gemma":[0.0246101,0.0007131341,0.00090692216,0.0017114988,0.0017334974,0.0026218898,0.002489397,0.013245427,0.0022673265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055616314,0.00095769344,0.04977789,0.00017534112,0.00013462114,0.002007382,0.003855294,0.00050815224,0.003563953,0.10819537,0.75851977,0.07174838],"study_design_scores_gemma":[0.00040283412,0.0006571852,0.16812408,0.0006136591,0.00037391612,0.0011305005,0.0041894233,0.004596491,0.014938424,0.011858119,0.79285777,0.00025763025],"about_ca_topic_score_codex":0.04866785,"about_ca_topic_score_gemma":0.08200296,"teacher_disagreement_score":0.04866785,"about_ca_system_score_codex":0.007451292,"about_ca_system_score_gemma":0.009289945,"threshold_uncertainty_score":0.096769154},"labels":[],"label_agreement":null},{"id":"W2039505100","doi":"10.1089/blr.2011.9983","title":"Expansion of the Canadian Research Exemption for Biotechnology Research Tools","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Library science; Experimental biology; Political science; Sociology; Law; Biology; Computer science; World Wide Web; Computational biology","score_opus":0.5336590373403922,"score_gpt":0.3447900543510486,"score_spread":0.18886898298934363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039505100","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028271297,0.0022121244,0.007872982,0.080029905,0.0033629884,0.0009908669,0.0033697814,0.00092800055,0.872962],"genre_scores_gemma":[0.2917307,0.0022278605,0.023772353,0.10931783,0.0014610811,0.00080609607,0.0023579956,0.00037602172,0.56795007],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9397637,0.0023876042,0.0017576,0.0036990643,0.042579066,0.009812969],"domain_scores_gemma":[0.9307673,0.0123272985,0.0014727087,0.0053872624,0.042995337,0.0070500355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019897074,0.0011677253,0.0011774135,0.009760168,0.017284432,0.014495751,0.0072872075,0.018802831,0.013958309],"category_scores_gemma":[0.04462401,0.0015459859,0.0029685956,0.004162137,0.006633093,0.0034045647,0.0056044105,0.0148254,0.0035811157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021728443,0.00020567635,0.0039050821,0.00030227404,0.000066087756,0.00083400187,0.002060368,0.0013099955,0.007460973,0.5790118,0.34996322,0.054663286],"study_design_scores_gemma":[0.00015096673,0.000098565506,0.017985728,0.00040908184,0.00012478791,0.00035909677,0.0007704456,0.0016542223,0.0034587625,0.014276372,0.9605014,0.00021053251],"about_ca_topic_score_codex":0.95195377,"about_ca_topic_score_gemma":0.9720435,"teacher_disagreement_score":0.9059241,"about_ca_system_score_codex":0.09407589,"about_ca_system_score_gemma":0.29547504,"threshold_uncertainty_score":0.68257153},"labels":[],"label_agreement":null},{"id":"W2608488164","doi":"10.1089/blr.2016.29030.mk","title":"A Decade of Data Protection for Innovative Drugs in Canada: Issues, Limitations, and Time for a Reassessment","year":2016,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CARE Canada","funders":"","keywords":"Intellectual property; Scope (computer science); Investment (military); Data Protection Act 1998; Treaty; Promotion (chess); Business; Welfare; Investment protection; International trade; Political science; International investment; Law; Foreign direct investment","score_opus":0.06956880997068911,"score_gpt":0.34301122955305424,"score_spread":0.27344241958236515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608488164","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024872893,0.04794749,0.0013489603,0.93166023,0.004190416,0.000040729556,0.00043053442,0.00006230603,0.011832039],"genre_scores_gemma":[0.07976375,0.08756874,0.008105675,0.8062022,0.003953924,0.00009548127,0.0006553011,0.00017160752,0.013483323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8954917,0.012420404,0.005453719,0.006054338,0.069640964,0.010938849],"domain_scores_gemma":[0.7116358,0.09904348,0.009500514,0.009542129,0.1409137,0.029364353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09520661,0.0008436261,0.0020672558,0.0056956015,0.018423758,0.030763417,0.0070889066,0.018093282,0.003956982],"category_scores_gemma":[0.13236883,0.0012634293,0.0022115042,0.008372334,0.039073978,0.016688544,0.0070330794,0.040585317,0.000796635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009865045,0.000088177214,0.0034279416,0.0013126921,0.000106290645,0.00048191432,0.006515735,0.00056331983,0.00061200646,0.35755938,0.5165148,0.11271902],"study_design_scores_gemma":[0.00004263548,0.0000446917,0.0047426578,0.0032192455,0.00006964018,0.00017652579,0.0040612184,0.00031065085,0.00043606487,0.020831093,0.9659018,0.0001637763],"about_ca_topic_score_codex":0.9614477,"about_ca_topic_score_gemma":0.9659117,"teacher_disagreement_score":0.7988479,"about_ca_system_score_codex":0.20115206,"about_ca_system_score_gemma":0.56293756,"threshold_uncertainty_score":0.9265504},"labels":[],"label_agreement":null},{"id":"W2974520714","doi":"10.1089/blr.2019.29135.rbk","title":"Disharmonization in the Regulation of Transgenic Plants in Europe","year":2019,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conestoga College","funders":"","keywords":"Parliament; European union; Member state; Legislation; Political science; Legislature; Member states; European commission; State (computer science); Genetically modified organism; Commission; Law; Public administration; Biotechnology; Business; International trade; Biology; Politics","score_opus":0.02205585330586195,"score_gpt":0.23129972475970484,"score_spread":0.20924387145384288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974520714","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52602094,0.0062201275,0.03776432,0.014014707,0.00068461377,0.00022273326,0.0003864635,0.0005369001,0.41414917],"genre_scores_gemma":[0.91896385,0.001638683,0.0071939966,0.009241636,0.000100690944,0.0001523244,0.0001917017,0.00007669593,0.06244044],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954139,0.0006424058,0.00032262265,0.0012189982,0.0015935393,0.00080847996],"domain_scores_gemma":[0.99682415,0.0018137333,0.00033090034,0.0004543835,0.0004074231,0.00016928786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00563867,0.00032947763,0.00033229525,0.0009117233,0.0017176119,0.003456014,0.0014194957,0.0075833173,0.0018804041],"category_scores_gemma":[0.0038710805,0.00032253118,0.0010942296,0.00058851455,0.0030582193,0.0013053517,0.0019242688,0.003575179,0.00028501236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002645185,0.00024381278,0.004641911,0.00014855842,0.00008465379,0.0012976942,0.0017142384,0.0028817786,0.10262595,0.8263699,0.008325723,0.05140133],"study_design_scores_gemma":[0.00026440743,0.001548162,0.06464359,0.0005591097,0.00051272754,0.0028116177,0.0019203231,0.010464088,0.19761431,0.17117706,0.54806226,0.00042239414],"about_ca_topic_score_codex":0.01593342,"about_ca_topic_score_gemma":0.012409359,"teacher_disagreement_score":0.01593342,"about_ca_system_score_codex":0.0025979881,"about_ca_system_score_gemma":0.0019838987,"threshold_uncertainty_score":0.03168136},"labels":[],"label_agreement":null},{"id":"W3172086909","doi":"10.1089/blr.2021.29236.mg","title":"The EPO Guidelines They Are a-Changin’","year":2021,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"","keywords":"European patent office; German; Convention; Law; Patent application; Political science; Medicine; Business; Library science; Computer science; History","score_opus":0.15415527396539966,"score_gpt":0.26218104747449233,"score_spread":0.10802577350909268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172086909","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023435883,0.0013194048,0.007379542,0.11381414,0.018704006,0.00045120885,0.0022140243,0.0009596385,0.85281444],"genre_scores_gemma":[0.012231402,0.0007794623,0.007270773,0.11018693,0.0028837067,0.00040199133,0.0010633938,0.00050769286,0.8646746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99063945,0.0014521591,0.0006454194,0.00083952834,0.0050609135,0.0013626091],"domain_scores_gemma":[0.9865298,0.0036111712,0.0005577006,0.0017448541,0.006922204,0.0006342035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007200527,0.00049861264,0.0006238781,0.0020497104,0.003803775,0.010521354,0.0021458818,0.0151311625,0.048434455],"category_scores_gemma":[0.031383473,0.0007616876,0.00092194515,0.0016153536,0.002468051,0.0036512478,0.0025207635,0.0114871105,0.026716558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001920514,0.00006012787,0.00026080894,0.000048372098,0.0000053419417,0.000100687736,0.0002418086,0.00008606096,0.00027821492,0.12116216,0.85818464,0.019552628],"study_design_scores_gemma":[0.00000998695,0.000007192933,0.00050055917,0.00006433752,0.000005007011,0.000037553447,0.00009363205,0.000079954036,0.00026102285,0.006653633,0.9922753,0.000011807198],"about_ca_topic_score_codex":0.035998035,"about_ca_topic_score_gemma":0.06498781,"teacher_disagreement_score":0.048434455,"about_ca_system_score_codex":0.0034575397,"about_ca_system_score_gemma":0.012762221,"threshold_uncertainty_score":0.16202945},"labels":[],"label_agreement":null},{"id":"W4214559639","doi":"10.1089/blr.2008.9935","title":"Third Circuit Accepts Preemption Arguments; More Cautions About Follow-On Biologics; Health Canada Issues Approval Guidance; FDA Takes First Steps in Expanding Drug Safety; Congress Proposes Requiring “Country of Origin” Statement; Congress Wants Direct Treatment Comparisons; Further Congressional Questions About Drug Advertising; Promised Studies Not Done; Warning over Avandia; Inspections of Foreign Facilities Will Not Be Easy; FDA Guidance on Genomics Term Definitions; European Scientists Want More Nanotechnology Regulation; Geron Stem Cell Trial on Hold; South Korea Clarifies Cloning Regulations; Decisions Needed on Antivirals in Advance of Flu Epidemic; Efforts to Control Genetic Testing; Bush Signs Genetic Information Nondiscrimination Act; Drug Companies Petition for Looser Restrictions on Literature on Off-Label Uses; Merck Said to Have Violated Publishing Ethics; Trade in Biotechnology Requires Closer Control; U.N. Alleges Chinese Dissidents Being Used as Organ Sources; Recent Approvals; Approval Delays?; NIH's Open Access Policy Still Has Publishers Roiled; Tilting at the FDA","year":2008,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preemption; Drug control; Federal preemption; Law; Medicine; Political science; Statute; Computer science","score_opus":0.14947012980974425,"score_gpt":0.3359656712391812,"score_spread":0.18649554142943695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214559639","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004615912,0.0015266541,0.0034320462,0.5635001,0.0077276328,0.00012575477,0.0010048103,0.00052273297,0.4175443],"genre_scores_gemma":[0.054747608,0.0007767573,0.0040400336,0.7384337,0.0039009617,0.00034263867,0.00025199875,0.00022517354,0.19728109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898953,0.0010706029,0.0005759315,0.0014358351,0.004517978,0.002504387],"domain_scores_gemma":[0.97755176,0.013335882,0.00051042956,0.0008866173,0.006908793,0.0008065759],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007838882,0.0010977224,0.0013859707,0.0019469081,0.017002946,0.016088057,0.004474525,0.057809997,0.021023436],"category_scores_gemma":[0.0349744,0.0010463918,0.003449615,0.0019140883,0.006298506,0.0076839454,0.0026570659,0.03161863,0.007855016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061335915,0.00006761508,0.00061582646,0.000051116484,0.000018007377,0.0003050115,0.0006041748,0.00014389488,0.00037731588,0.43816712,0.5528845,0.006704004],"study_design_scores_gemma":[0.00014528556,0.00007116818,0.0015389753,0.00021183121,0.00013107632,0.00018500049,0.0005933058,0.000823458,0.0013215899,0.06569674,0.929163,0.00011864321],"about_ca_topic_score_codex":0.14716631,"about_ca_topic_score_gemma":0.19553345,"teacher_disagreement_score":0.9921611,"about_ca_system_score_codex":0.011477948,"about_ca_system_score_gemma":0.019543126,"threshold_uncertainty_score":0.2926194},"labels":[],"label_agreement":null},{"id":"W4234058516","doi":"10.1089/blr.2010.9960","title":"In the High Court of Justice Before The Hon. Mr. Justice Arnold: <i>Intervet UK Ltd. v. Merial, the Queen's University of Belfast, and the University of Saskatchewan</i> (Case no. HC09C00779)","year":2010,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Conflict of Laws and Jurisdiction","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Queen (butterfly); Economic Justice; Law; Sociology; Biology; Political science; Botany","score_opus":0.006586631673614615,"score_gpt":0.23238556536232835,"score_spread":0.22579893368871373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234058516","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01946944,0.004402921,0.0013171316,0.68104297,0.016859137,0.00016419575,0.00079185003,0.00016426889,0.27578804],"genre_scores_gemma":[0.096510805,0.0009838574,0.0007838843,0.5120934,0.002163407,0.0001364443,0.00019470144,0.00012709605,0.38700643],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940661,0.0005351221,0.00028811747,0.0009103069,0.001623172,0.002577188],"domain_scores_gemma":[0.9957487,0.002105923,0.00013871536,0.00015838844,0.0010138814,0.0008344658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037010498,0.0005252623,0.00096945587,0.0007995333,0.02653173,0.010689012,0.0025527962,0.027414534,0.018780177],"category_scores_gemma":[0.01598029,0.00094678154,0.0010699787,0.00090956927,0.0037730895,0.0036760038,0.0040430496,0.028481167,0.004686309],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048878235,0.000041992058,0.0010802952,0.00004500054,0.000021071322,0.0014709937,0.0024354197,0.00006521273,0.0005695598,0.1315513,0.8563915,0.006278805],"study_design_scores_gemma":[0.00004206089,0.000034266,0.0032593098,0.00022646574,0.00006828718,0.00048557136,0.0052882303,0.00027614724,0.0012383191,0.026918063,0.96206206,0.000101179125],"about_ca_topic_score_codex":0.19795176,"about_ca_topic_score_gemma":0.43589395,"teacher_disagreement_score":0.8020482,"about_ca_system_score_codex":0.010149983,"about_ca_system_score_gemma":0.014959707,"threshold_uncertainty_score":0.3935991},"labels":[],"label_agreement":null},{"id":"W4234700261","doi":"10.1089/blr.2012.9649","title":"Canada Cancels Pfizer's Viagra Patent","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Patent law; Download; Volume (thermodynamics); Political science; Business; Law; Intellectual property; Computer science; World Wide Web; Physics","score_opus":0.018694338335708063,"score_gpt":0.2323175447619683,"score_spread":0.21362320642626026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234700261","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011009639,0.0036266018,0.0015240799,0.29854208,0.031207813,0.0005334576,0.0033357993,0.0012799149,0.6489407],"genre_scores_gemma":[0.031731233,0.0013445821,0.0008424296,0.12538436,0.0026066084,0.00007764449,0.00072563643,0.00023814496,0.83704937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98595154,0.00021112911,0.00023082862,0.0006982057,0.009884958,0.0030232049],"domain_scores_gemma":[0.9877957,0.0022406126,0.00023186192,0.00047443493,0.007045668,0.0022117088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003992394,0.0010466175,0.0013993843,0.003093266,0.010022892,0.012306186,0.0038115236,0.043537978,0.033417236],"category_scores_gemma":[0.018380053,0.0010240498,0.0021115628,0.0015620653,0.0028831833,0.0025749956,0.0020500254,0.016810227,0.011641171],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006565578,0.000065498694,0.00053723034,0.000035510096,0.000023895363,0.00036199886,0.00008347177,0.00007989642,0.0004919429,0.03487653,0.9519931,0.011385191],"study_design_scores_gemma":[0.000068207475,0.000045584624,0.0016234064,0.000053487263,0.00004141003,0.00013852809,0.00013112501,0.0002742728,0.00069065904,0.0016980646,0.99520147,0.000033757227],"about_ca_topic_score_codex":0.81299585,"about_ca_topic_score_gemma":0.91483474,"teacher_disagreement_score":0.18700415,"about_ca_system_score_codex":0.033407405,"about_ca_system_score_gemma":0.16305393,"threshold_uncertainty_score":0.37621087},"labels":[],"label_agreement":null},{"id":"W4239469862","doi":"10.1089/blr.2011.9992","title":"A Close Look at Non-Inferiority Trials; FDA Issues Guidance on Safety for Clinical Trials; Geron Human Embryonic Stem Cell Trial Starts; National Academy of Sciences Discusses Postmarketing Trials; Bone Marrow Stem Cell Trial Authorized in Israel; Canadian Company Asked to Submit Proposal on Brain Injury Treatment to DoD","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Stem cell; Medicine; Embryonic stem cell; Internal medicine; Biology","score_opus":0.21796774631967103,"score_gpt":0.4613964784922311,"score_spread":0.24342873217256006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239469862","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024010263,0.01449717,0.0057204342,0.9230056,0.018141326,0.00024576977,0.00011042799,0.00016235672,0.03787675],"genre_scores_gemma":[0.003394141,0.0031368574,0.0069122016,0.95858586,0.016558595,0.0003149172,0.000032371663,0.00016798195,0.0108969575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.82081443,0.1156857,0.016057143,0.00864051,0.034277644,0.0045244587],"domain_scores_gemma":[0.40850043,0.5370626,0.010402395,0.009132317,0.026715461,0.008186848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16372572,0.002359066,0.005347051,0.0056265746,0.010507281,0.025943642,0.008588112,0.17248492,0.01363193],"category_scores_gemma":[0.33826756,0.0034923956,0.0056849336,0.0031974532,0.03709602,0.019998003,0.0067081545,0.1163325,0.008709499],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011155789,0.00012008957,0.0002628303,0.0007127041,0.00008681023,0.00065801176,0.0010477905,0.0001829365,0.00042808944,0.13547587,0.830005,0.03090838],"study_design_scores_gemma":[0.00040035337,0.00015481641,0.0007412516,0.00320859,0.0001460909,0.0010241449,0.0005206404,0.0003986549,0.0003577693,0.15142988,0.8414231,0.00019465259],"about_ca_topic_score_codex":0.0075158393,"about_ca_topic_score_gemma":0.024443928,"teacher_disagreement_score":0.17248492,"about_ca_system_score_codex":0.009991236,"about_ca_system_score_gemma":0.025847813,"threshold_uncertainty_score":0.8658747},"labels":[],"label_agreement":null},{"id":"W4243854610","doi":"10.1089/blr.2012.9659","title":"Canada May Not Approve Generic Versions of OxyContin","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Volume (thermodynamics); Political science; Library science; Computer science; World Wide Web; Physics","score_opus":0.08033790925893307,"score_gpt":0.20725504633265995,"score_spread":0.12691713707372687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243854610","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06593583,0.002585013,0.0037916868,0.029766701,0.002128297,0.00069083396,0.0043869284,0.002147169,0.8885675],"genre_scores_gemma":[0.31585804,0.0016847142,0.0046101906,0.055035707,0.00071032,0.00026727756,0.0030128348,0.00046512476,0.61835575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567175,0.00028926207,0.00018733153,0.00039170607,0.0024403506,0.0010196677],"domain_scores_gemma":[0.9893818,0.0026512346,0.00048801483,0.0015598794,0.0052895444,0.00062951713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004143817,0.00044016298,0.00043297515,0.0014319528,0.004341794,0.0037679116,0.002660719,0.007841545,0.027541816],"category_scores_gemma":[0.011255329,0.00058140495,0.0011797757,0.0013052144,0.0022959393,0.001661533,0.0011850743,0.0040591657,0.0048191035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009464475,0.0002706053,0.011794904,0.00040814068,0.0001067522,0.001531852,0.0013776589,0.0006760254,0.009948995,0.19087254,0.68121356,0.10085252],"study_design_scores_gemma":[0.00015300394,0.00018214222,0.016161125,0.00019811497,0.00010528512,0.00051470246,0.00035636473,0.00058392435,0.004064724,0.0044134534,0.97319734,0.000069732836],"about_ca_topic_score_codex":0.49782333,"about_ca_topic_score_gemma":0.63773966,"teacher_disagreement_score":0.50217664,"about_ca_system_score_codex":0.01276409,"about_ca_system_score_gemma":0.029140089,"threshold_uncertainty_score":0.98985136},"labels":[],"label_agreement":null},{"id":"W4246441873","doi":"10.1089/blr.2009.9923","title":"FDA Cannot Write Definitions on Its Own; APHIS Releases Biotechnology Quality Management System; Environmental Impact Statement Needed for Alfalfa; EU Finds Monsanto Corn Safe; High-Oleic Soybeans Okayed; Farmer Irritated with Biotechnology Opponents; Canada Drops Canola Complaint Against WTO; Cambridge to Ban Level 4 Laboratories; Restriction on Use of Antibiotics in Animal Field; Eight-Feature Corn Gets U.S., Canadian Approval","year":2009,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aphis; Canola; Agricultural science; Biotechnology; Business; Biology; Agronomy","score_opus":0.053854485882311495,"score_gpt":0.25738178063837736,"score_spread":0.20352729475606585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246441873","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008880874,0.0030575092,0.011866703,0.03628551,0.0065743863,0.0005383588,0.0048826784,0.0015085943,0.9343982],"genre_scores_gemma":[0.022947485,0.005965628,0.023594951,0.11933623,0.003560879,0.0025126906,0.01636033,0.001985864,0.80373603],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98198706,0.0031176645,0.0015369365,0.0012987253,0.010518697,0.0015409122],"domain_scores_gemma":[0.95293266,0.010241131,0.0027188754,0.0045198677,0.028377159,0.0012104068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010076669,0.0010916048,0.0011510393,0.0031947615,0.0051880367,0.009771462,0.0039543067,0.009158923,0.06471442],"category_scores_gemma":[0.03325324,0.001075902,0.001417346,0.0037454348,0.003490237,0.007068727,0.0024534154,0.009206729,0.08630452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023334374,0.000043078737,0.00017412331,0.00014988681,0.0000037094974,0.000049272305,0.00019707775,0.00005388628,0.00081547175,0.06663556,0.90583664,0.026018007],"study_design_scores_gemma":[0.0000076874485,0.00001646753,0.00018862472,0.00012453455,0.0000039812376,0.00004592791,0.000081463884,0.00003377832,0.0002771031,0.0036746643,0.9955356,0.000010326721],"about_ca_topic_score_codex":0.022250846,"about_ca_topic_score_gemma":0.023883326,"teacher_disagreement_score":0.97774917,"about_ca_system_score_codex":0.005450916,"about_ca_system_score_gemma":0.013469791,"threshold_uncertainty_score":0.21649128},"labels":[],"label_agreement":null},{"id":"W4249687475","doi":"10.1089/blr.2007.9911","title":"PTO Agrees to Review Patents on Anti-HIV Drug; Canadian Decision May or May Not Have Profound Implications; PTO Strives to Get a Handle on <i>Markush</i> Claim; CAFC Agrees Patent Law Preempts D.C. Price-Control Measure","year":2007,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Patent law; Law; Control (management); Political science; Law and economics; Business; Economics; Medicine; Virology; Intellectual property; Management","score_opus":0.084812807088495,"score_gpt":0.31325044976366906,"score_spread":0.22843764267517405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249687475","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006071235,0.0012825328,0.0017885214,0.3397746,0.0072713704,0.0003504222,0.0033144592,0.00064371544,0.63950306],"genre_scores_gemma":[0.057952,0.00084415043,0.0029329178,0.21586789,0.0021673136,0.00015524044,0.0009741075,0.00023515413,0.7188711],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98776895,0.0004990047,0.00044036587,0.001084619,0.0070964578,0.0031105008],"domain_scores_gemma":[0.9767346,0.004775369,0.00071984925,0.0012986439,0.013441394,0.0030302608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061936444,0.00048493137,0.0014425946,0.0018193983,0.012656962,0.008650252,0.0033101737,0.029360691,0.05251686],"category_scores_gemma":[0.027419131,0.00084792887,0.001923267,0.0022832756,0.00274847,0.003338287,0.0016035364,0.014266463,0.0209371],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011046206,0.00006648377,0.00111905,0.00006232226,0.000028140183,0.00034766106,0.00019433639,0.00008829745,0.00092762714,0.053175174,0.9340856,0.009794846],"study_design_scores_gemma":[0.00006141919,0.0000437905,0.003506765,0.00006997495,0.00006327283,0.0001920552,0.00021871,0.00045362997,0.0018227443,0.0048973444,0.98859113,0.00007916825],"about_ca_topic_score_codex":0.48018494,"about_ca_topic_score_gemma":0.66934043,"teacher_disagreement_score":0.5198151,"about_ca_system_score_codex":0.020346606,"about_ca_system_score_gemma":0.06962698,"threshold_uncertainty_score":0.9547799},"labels":[],"label_agreement":null},{"id":"W4251060970","doi":"10.1089/0730031041724837","title":"Schmeiser <i>v.</i> Monsanto Canada Inc.,","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Download; Statutory law; Law; Statutory interpretation; Political science; Computer science; World Wide Web","score_opus":0.04458843433448383,"score_gpt":0.19539434234246,"score_spread":0.15080590800797616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251060970","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015186497,0.00710533,0.0011843265,0.18463959,0.002182039,0.00020667938,0.0030567104,0.0004662538,0.78597254],"genre_scores_gemma":[0.07526373,0.0029411055,0.001080472,0.21031813,0.00036529,0.00013668499,0.0010522716,0.00013675775,0.70870554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965089,0.00015657021,0.000086340464,0.00028880456,0.0015542135,0.0014052168],"domain_scores_gemma":[0.9967895,0.000843855,0.00010482048,0.000077044424,0.0018302116,0.00035463186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017565407,0.0007298569,0.00036046613,0.0018043562,0.016566752,0.0074493424,0.0022892896,0.012948831,0.026056366],"category_scores_gemma":[0.0060845832,0.00077144644,0.0007678238,0.0015431767,0.0020368302,0.002206826,0.0014663152,0.008507408,0.0060861493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006573398,0.000039004637,0.0028521165,0.00009375045,0.0000143815,0.0004292387,0.0008624223,0.0001628852,0.00096765393,0.071698315,0.90989643,0.012918047],"study_design_scores_gemma":[0.000038131424,0.000028740345,0.0071991617,0.00015666882,0.00005074035,0.00014672786,0.001560241,0.00038256487,0.0017190352,0.00577772,0.98286796,0.00007236521],"about_ca_topic_score_codex":0.8462131,"about_ca_topic_score_gemma":0.95242923,"teacher_disagreement_score":0.1537869,"about_ca_system_score_codex":0.017793445,"about_ca_system_score_gemma":0.05103108,"threshold_uncertainty_score":0.30938512},"labels":[],"label_agreement":null},{"id":"W4252964882","doi":"10.1089/blr.2006.25.389","title":"First Product from Transgenic Animal Cleared in Europe; Mab Associated with Brain Infection Allowed Back on Market; Should U.S. Approve Follow-On Biologics?; D.C. Court of Appeals Finds Constitutional Right to Unapproved Drugs; Participating in Efforts Against Counterfeiters; Specifications Issued for Veterinary Biologics and Biotechnology Products; Electronic Communications Are Desirable for Important Drug Information; Guidance for Antiviral Drug Development; Short Stories: New Indication for Remicade; Bone Stimulant Approved in Canada","year":2006,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clearance; Product (mathematics); Supreme court; Medicine; Food and drug administration; Law; Political science; Pharmacology","score_opus":0.0803028059876358,"score_gpt":0.24328393472962664,"score_spread":0.16298112874199083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252964882","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014108458,0.010586996,0.0062307636,0.018557336,0.002359439,0.00038050063,0.0046977,0.001675762,0.94140303],"genre_scores_gemma":[0.08378611,0.004764364,0.006624137,0.011469198,0.00032597635,0.00012223916,0.0026579332,0.00029963694,0.88995034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952626,0.000026699247,0.000010479184,0.000046802368,0.0003050361,0.000084706604],"domain_scores_gemma":[0.9993944,0.00011425626,0.00005260123,0.00005923327,0.00026071267,0.000118696276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006200984,0.0003809794,0.00025707774,0.0012448243,0.0016059269,0.001539317,0.0005869827,0.0025581915,0.051772267],"category_scores_gemma":[0.0011197013,0.0003112146,0.00041584444,0.00042994536,0.00091744895,0.00054197543,0.0004251196,0.0019356903,0.010906293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035738433,0.00025037615,0.0025125532,0.00025769873,0.00003887905,0.001503755,0.0003430451,0.00019795337,0.04703433,0.05227821,0.7606055,0.13462028],"study_design_scores_gemma":[0.00006618477,0.00009543131,0.003097662,0.000078042154,0.000021371809,0.0005075571,0.00005052364,0.00009696455,0.008376987,0.0015272818,0.9860686,0.000013328844],"about_ca_topic_score_codex":0.05628832,"about_ca_topic_score_gemma":0.20348203,"teacher_disagreement_score":0.9437117,"about_ca_system_score_codex":0.0032156145,"about_ca_system_score_gemma":0.004567128,"threshold_uncertainty_score":0.17319548},"labels":[],"label_agreement":null}]}